Xacduro (Sulbactam/Durlobactam) for Acinetobacter Pneumonia: First Targeted Hospital Pneumonia Antibiotic (FDA 2023)
Xerava (Eravacycline) for Complicated Intra-Abdominal Infections: Fluorocycline Antibiotic Explained (FDA 2018)
Dalvance (Dalbavancin) for Skin Infections: Single-Dose and Two-Dose Options Explained (FDA 2014)
Fetroja (Cefiderocol) for Complicated UTIs: First Siderophore Cephalosporin and the Mortality Warning Every Patient Should Know (FDA Approved 2019)
